Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

Fig. 7

Analysis of the 64 key targets associated with the 4 validated active compounds of SH003 using KEGG. The enriched KEGG terms are depicted on the Y-axis, while the X-axis denotes “% Associated Genes”, representing the percentage of genes within the specified KEGG term. Dot size indicates the number of genes associated with specific terms, and the color of the dots corresponds to the -Log(P value)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us